Related references
Note: Only part of the references are listed.Nifurtimox-Eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness:: A randomized clinical trial in Congo
Gerardo Priotto et al.
CLINICAL INFECTIOUS DISEASES (2007)
Equivalence trial of Melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness
Sylvie Bisser et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness:: A randomized clinical trial in Uganda
Gerardo Priotto et al.
PLOS CLINICAL TRIALS (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Anti-trypanosomal activities of DNA topoisomerase inhibitors
A Deterding et al.
ACTA TROPICA (2005)
Chemotherapy of human African trypanosomiasis: current and future prospects
AH Fairlamb
TRENDS IN PARASITOLOGY (2003)
DNA topoisomerases as targets for anticancer drugs
Z Topcu
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2001)
Share Paper
